They developed a mouse model of COVID-19 where wild-type 6-week-old mice were intraperitoneally injected with adeno associated virus serotype 9 (AAV-9) encoding the human ACE2 (hACE2) transgene, followed by injection of SARS-CoV-2 virus isolate after 2 weeks. The gene discussed is ACE2; the disease is COVID-19.